Showing results (441-450 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|January 17, 2018
The Current Status of Outcomes-Based Contracting for Manufacturers and Payers: An AMCP Membership SurveyAmy M Duhig, Soumi Saha, Stacie Smith, et al.Journal of Managed Care & Specialty Pharmacy|February 28, 2018
Implementation of a Proactive Pilot Health Plan-Driven Opioid Tapering Program to Decrease Chronic Opioid Use for Conditions of the Back and Spine in a Medicaid PopulationJulia Page, Robin Traver, Sital Patel, et al.Journal of Managed Care & Specialty Pharmacy|February 28, 2018
Differences in Medicaid Antipsychotic Medication Measures Among Children with SSI, Foster Care, and Income-Based AidEmily Leckman-Westin, Molly Finnerty, Sarah Hudson Scholle, et al.Journal of Managed Care & Specialty Pharmacy|February 1, 2018
Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIVThomas J Dilworth, Pamela W Klein, Renée-Claude Mercier, et al.Journal of Managed Care & Specialty Pharmacy|February 1, 2018
The Effect of Florida Medicaid's State-Mandated Formulary Provision on Prescription Drug Use and Health Plan Costs in a Medicaid Managed Care PlanKiraat D Munshi, Douglas Mager, Krista M Ward, et al.Journal of Managed Care & Specialty Pharmacy|January 2, 2018
Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United StatesJosh J Carlson, Gregory F Guzauskas, Richard H Chapman, et al.Journal of Managed Care & Specialty Pharmacy|January 2, 2018
Eight-Week Outcomes of Ledipasvir/Sofosbuvir in Noncirrhotic Treatment-Naive Patients with Hepatitis C: Analysis of Pharmacy-Based DataJennifer Andres, Stephen Lott, Kamran QureshiJournal of Managed Care & Specialty Pharmacy|January 2, 2018
Future Considerations for the Evaluation of Hepatitis C Virus Treatments in Pan-Genotypic Therapy for Noncirrhotic Treatment-Naive PatientsMartin J Calabrese, Lauren M Hynicka, Magaly Rodriguez de Bittner, et al.Journal of Managed Care & Specialty Pharmacy|January 2, 2018
Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United StatesRahul Jain, An-Chen Fu, Jonathan Lim, et al.Journal of Managed Care & Specialty Pharmacy|May 29, 2020
Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung CancerNicole M Engel-Nitz, Michael P Johnson, Scott H Bunner, et al.Pageof 185